Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer

Area of Science:

• Oncology
• Cell Biology
• Cancer Therapeutics

Background:

• Cellular senescence is a stable cell-cycle arrest triggered by stressors like DNA damage.
• Senescent cells secrete factors (senescence-associated secretory phenotype, SASP) influencing the microenvironment.
• Senescence has a dual role: tumor suppression and promotion of inflammation/oncogenesis.

Purpose of the Study:

• To review the role of cellular senescence in cancer biology.
• To discuss emerging senescence-targeted therapies.
• To examine senescence's role in head and neck cancers (HNC) and induced senescence therapy potential.

Main Methods:

• Literature review on cellular senescence, SASP, and cancer biology.
• Analysis of senescence's dual role in tumor suppression and promotion.
• Focus on head and neck cancers and potential therapeutic strategies.

Main Results:

• Cellular senescence is a complex process with both beneficial (tumor suppression) and detrimental (inflammation, oncogenesis) effects.
• Senescence-associated secretory phenotype (SASP) significantly impacts the tumor microenvironment.
• Induced senescence therapy shows promise for mitigating head and neck cancer progression.

Conclusions:

• Understanding the dual nature of cellular senescence is crucial for developing effective cancer treatments.
• Targeting senescence offers innovative therapeutic strategies for head and neck cancers.
• Further research is needed to optimize senescence-based therapies and overcome challenges.